Board votes to cap how much state, local governments spend on Ozempic

By: Danielle J. Brown

Outlets: Maryland Matters

Published: May 19, 2026

Words: 899

Last Updated: 2 months ago

Body Text Preview

State officials determined that Ozempic, a popular diabetes treatment and weight-loss drug, is unaffordable for Marylanders and voted Monday to limit how much state and local governments will pay for it on state health plans.

Advocates say the Maryland Prescription Drug Affordability Board’s proposed “upper payment limit” on Ozempic, the name brand for semaglutide, could save state and local governments around $5.8 million a year on state health plans.

The board’s decision comes a month …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us